(Q52965951)

10 May 2018

title

Attitudes to chemotherapy in patients with ovarian cancer. (English)

1 reference

10 May 2018

1 reference

1 reference

Penson RT

1

1 reference

10 May 2018

Dignan F

2

1 reference

10 May 2018

Seiden MV

3

1 reference

10 May 2018

Lee H

4

1 reference

10 May 2018

Gallagher CJ

5

1 reference

10 May 2018

Matulonis UA

6

1 reference

10 May 2018

Olson K

7

1 reference

10 May 2018

Gibbens I

8

1 reference

10 May 2018

Gore ME

9

1 reference

10 May 2018

language of work or name

English

0 references

publication date

1 August 2004

1 reference

10 May 2018

published in

Gynecologic Oncology

1 reference

10 May 2018

volume

94

1 reference

10 May 2018

issue

2

1 reference

10 May 2018

page(s)

427-435

1 reference

10 May 2018

cites work

Cancer statistics, 2000.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.034

Chemotherapy for ovarian cancer--a consensus statement on standard practice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.034

Advanced epithelial ovarian cancer: 1998 consensus statements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.034

The CA 125 assay as a predictor of clinical recurrence in epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.034

Clinical trials in patients with epithelial ovarian cancer: past, present and future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.034

Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.034

Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.034

The impact of cytotoxic chemotherapy - perspectives from patients, specialists and nurses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.034

Attitudes of non-oncology physicians dealing with cancer patients. A survey based on clinical scenarios in Ancona province, central Italy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.034

Cancer patients, doctors and nurses vary in their willingness to undertake cancer chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.034

Non-small cell lung cancer: how oncologists want to be treated

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.034

Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.034

Physician factors in the timing of cancer patient referral to hospice palliative care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.034

Part II: chemotherapy for epithelial ovarian cancer-treatment of recurrent disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.034

Are older French patients as willing as older American patients to undertake chemotherapy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.034

Anxiety and uncertainty in informed decision making.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.034

Chemotherapy Use among Medicare Beneficiaries at the End of Life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.034

Docetaxel in ovarian cancer: phase III perspectives and future development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.034

Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.034

Quality of Life of Women with Ovarian Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.034

Does palliative chemotherapy palliate? Evaluation of expectations, outcomes, and costs in women receiving chemotherapy for advanced ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.034

10.1016/J.YGYNO.2004.05.034

7 January 2021

Identifiers

DOI

1 reference

10 May 2018

1 reference

10 May 2018